Clinical Trial Update: Clinical Trial To Evaluate ANT-1207 In Participants With Primary Axillary Hyperhidrosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ANT-1207 for primary axillary hyperhidrosis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperhidrosis

Drugs mentioned

• ANT-1207

Snippet

Sponsor: Allergan | Conditions: Hyperhidrosis | Phase 2 | Status: COMPLETED | Results posted: 2017-09-20